Engela Helena Conradie

Engela Helena Conradie


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
ECEngela Helena Conradie
Engela Helena Conradie
HMHelen Malherbe
Helen Malherbe
CHChristian J. Hendriksz
Christian J. Hendriksz
MDMarli Dercksen
Marli Dercksen
BVBarend C. Vorster
Barend C. Vorster
The North-West University's Centre for Human Metabolomics (CHM) is in the process of establishing the first rare disease (RD) biobank in South Africa and Africa. The CHM Biobank's main focus is on the collection of samples and information for rare congenital disorders. Approximately 72% of all RDs have a genetic origin, of which 70% have an exclusive pediatric onset. The need for such a biobank was identified by the CHM diagnostic laboratory. Feedback toward this initiative was overwhelmingly positive at the first stakeholder meeting in August 2019. However, gaining support from the public sector and recruiting of participants have proven to be challenging. Problems experienced to date include lack of support from government and clinicians; lack of knowledge on RDs (patients and clinicians); public health care focus not directed toward RDs; patients not returning for follow-up visits; and unwillingness to participate due to fear of exploitation. The CHM Biobank's vision and goals are aligned to address a national and international research need: it will provide a valuable resource for scientists to improve what is known about these diseases; to better understand the natural history and pathophysiology; to optimize diagnostic methods; and to potentially develop treatments. The genetic variability of the South African population provides added value to the RD biobank. This review provides a brief overview of the literature on the challenges and benefits of an RD biobank and how this relates to low- and middle-income countries (LMIC) like South Africa. The aim of the review is to draw attention to the potential benefits of such an undertaking and to create awareness, at both local and global level, toward some of the unique collective considerations that an RD biobank in LMIC (also unique South African challenges) faces on an operational, collaborate, and sustainability level.

4 December 2023 in South African Medical Journal
Verified
Journal Article
Open access
PDF file
MDMarli Dercksen
Marli Dercksen
ECEngela Helena Conradie
Engela Helena Conradie
CHC J Hendriksz
C J Hendriksz
HMH Malherbe
H Malherbe
BVBarend Christiaan Vorster
Barend Christiaan Vorster

1 November 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
Tozivepi Aaron MunyayiTozivepi Aaron Munyayi
Tozivepi Aaron Munyayi
DMDanielle Wingrove Mulder
Danielle Wingrove Mulder
ECEngela Helena Conradie
Engela Helena Conradie
FSFrans Smit
Frans Smit
BVBarend Christiaan Vorster
Barend Christiaan Vorster
We describe a competitive colorimetric assay that enables rapid and sensitive detection of galactose and reduced nicotinamide adenine dinucleotide (NADH) via colorimetric readouts and demonstrate its usefulness for monitoring NAD+-driven enzymatic reactions. We present a sensitive plasmonic sensing approach for assessing galactose concentration and the presence of NADH using galactose dehydrogenase-immobilized gold nanostars (AuNS-PVP-GalDH). The AuNS-PVP-GalDH assay remains turquoise blue in the absence of galactose and NADH; however, as galactose and NADH concentrations grow, the reaction well color changes to a characteristic red color in the presence of an alkaline environment and a metal ion catalyst (detection solution). As a result, when galactose is sensed in the presence of H2O2, the colored response of the AuNS-PVP-GalDH assay transforms from turquoise blue to light pink, and then to wine red in a concentration-dependent manner discernible to the human eye. This competitive AuNS-PVP-GalDH assay could be a viable analytical tool for rapid and convenient galactose quantification in resource-limited areas.

10 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Tozivepi Aaron MunyayiTozivepi Aaron Munyayi
Tozivepi Aaron Munyayi
DMDanielle Wingrove Mulder
Danielle Wingrove Mulder
ECEngela Helena Conradie
Engela Helena Conradie
BVBarend Christiaan Vorster
Barend Christiaan Vorster
We describe a competitive colorimetric assay that enables rapid and sensitive detection of galactose and reduced nicotinamide adenine dinucleotide (NADH) via colorimetric readouts and demon-strates its usefulness for monitoring NAD+-driven enzymatic reactions. We present a sensitive plasmonic sensing approach for assessing galactose concentration and the presence of NADH using galactose dehydrogenase immobilized gold nanostars (AuNS-PVP-GalDH). The AuNS-PVP-GalDH assay remains turquoise blue in the absence of galactose and NADH; however, as galactose and NADH concentrations grow, the reaction well color changes to a characteristic red color in the presence of an alkaline environment and metal ions catalyst (detection solution). As a result, when galactose is sensed in the presence of H2O2, the colored response of the AuNS-PVP-GalDH assay transforms from turquoise blue to light pink, then to wine red in a con-centration-dependent manner discernible to the human eye. This competitive AuNS-PVP-GalDH assay could be a viable analytical tool for rapid and convenient galactose quantification in re-source-limited areas.